HIGHLIGHTS
- who: Fabio Giglio from the University of Texas MD Anderson Cancer Center, United States have published the Article: Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation, in the Journal: (JOURNAL)
SUMMARY
Hepatic Sinusoidal Obstruction Syndrome (SOS) is a potentially life-threatening complication of Hematopoietic Stem Cell Transplantation (HSCT). While mild SOS are underdiagnosed and spontaneously resolve, severe cases might evolve in liver dysfunction and multiple organ failure (MOF). Several transplant, patient, and liver-related risk factors have been suggested and, among them, the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.